PHOENIX--(BUSINESS WIRE)--Synovics Pharmaceuticals, Inc., (OTCBB:SYVC) a specialty pharmaceutical company, today announced that David Coffin-Beach, Ph.D., has been appointed President and Chief Operating Officer. In this role he will be responsible for, and have reporting to him management of, the Company’s operating subsidiaries, Kirk Pharmaceuticals, Inc., ANDAPharm, Inc. and Synovics Laboratories, Inc.
